Search

everythinglearnresearchcommunity

for

Search:↓

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Obese women with PCOS are more likely to have fatty liver disease.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

MC4R gene variants not linked to female hair loss.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.